Remove 2012 Remove Medical Remove Therapy
article thumbnail

Malignant Melanoma

First Derm

Malignant Melanoma Medically reviewed by The Dermatologists and written by Dr. Alexander Börve In A Nutshell Common More than 200,000 US cases per year Requires medical diagnosis Symptoms: Abnormal growth in moles Color: Typically brown Location: Anywhere on the skin Treatment: Surgery, Chemotherapy Death Rate Incident Rate ICD-10: C43.9

Surgery 98
article thumbnail

How Can These Devices Help with Healthy Aging

Lipgloss and Aftershave

As you establish these new habits, consider light therapy as a great way to support your whole-body wellness goals, it can be a great path to healthy aging. Since joining Celluma in 2012, she has held key roles, currently serving as the Global Vice President of Brand Management. Denis directs sales to various healthcare professionals.

article thumbnail

Median Nail Dystrophy

First Derm

Median Nail Dystrophy Medically reviewed by Dennis A Porto, MD and The Dermatologists Median Nail Dystrophy (01) finger nail [ICD-10 L60.3] Another factor that has been reported to cause median nail dystrophy is medication, such as oral isotretinoin. Should I seek medical care? ICD-9: 703.8 Dystrophies of the nail.

article thumbnail

Pediatric Psoriasis: Characteristics of a Cohort at UCSF Spanning 2 Decades

The Dermatology Digest

“There has been a substantial increase in the use of systemic and biologic therapies over time, which is an important step in bridging the treatment gap for moderate-to-severe pediatric psoriasis patients,” noted Carmel Aghdasi, BA, one of the study authors.

article thumbnail

Ozempic vs Berberine: What's the Difference?

Aesthetics Advisor

Ozempic and Wegovy are prescription medications that are said to directly target gut hormones involved in appetite and blood sugar. History of Ozempic 2012: Semaglutide, the active ingredient in both Wegovy and Ozempic, was developed by Novo Nordisk. Here are their differences, research highlights, and how they work.

article thumbnail

Cut, Poison, Burn — Is Radiation Treatment on the Way Out?

Aesthetics Advisor

The idea of using toxic therapies to destroy tumors should represent a last resort, if used at all, not a first-line treatment. So we decided to do another study to see if radioiodine therapy was even useful.” By 2040, it’s expected that 29.5 million new cancer cases will occur each year, along with 16.4 million cancer-related deaths.

article thumbnail

Pediatric Psoriasis: Characteristics of a Cohort at UCSF Spanning 2 Decades

The Dermatology Digest

“There has been a substantial increase in the use of systemic and biologic therapies over time, which is an important step in bridging the treatment gap for moderate-to-severe pediatric psoriasis patients,” noted Carmel Aghdasi, BA, one of the study authors.